Bausch + Lomb
Makes contact lenses, eye-care products, ophthalmic medicines, and surgical tools.
$17.15
After-hours close0.00 (0.00%)
At close$17.15(+0.12%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 10.63%37.97M sharesInsiders 0.89%3.16M sharesOther 88.48%316.03M shares
Shares outstanding 357.17M · Float 45.55M · 12.8% free float
Institutions13F, as of Mar 31, 2026
100 holders · 37.97M shares · 18 new positions · 53 increased · 25 reduced · 20 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Deutsche Bank AG\ | 3.53M | 0.99% | +78.4K | May 6, 2026 |
| Icahn Carl C | 3.50M | 0.98% | 0 | May 15, 2026 |
| Oaktree Capital Management LP | 3.38M | 0.95% | 0 | May 20, 2026 |
| D. E. Shaw & Co., Inc. | 3.15M | 0.88% | +304.5K | May 15, 2026 |
| Goldentree Asset Management LP | 2.66M | 0.74% | 0 | May 14, 2026 |
| Silver Point Capital L.P. | 2.25M | 0.63% | −320.0K | May 15, 2026 |
| Davidson Kempner Capital Management LP | 2.20M | 0.62% | +259.5K | May 15, 2026 |
| Caspian Capital LP | 2.00M | 0.56% | 0 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Brent L. Saunders | director, officer: Chairman of the Board and CEO | 1.26M | 0.35% | Aug 7, 2026 |
| Sam Eldessouky | officer: EVP and CFO | 393.5K | 0.11% | Aug 7, 2026 |
| A. Robert D. Bailey | officer: EVP & Chief Legal Officer | 264.2K | 0.07% | Aug 7, 2026 |
| Yehia Hashad | officer: EVP of R&D and CMO | 187.4K | 0.05% | Aug 7, 2026 |
| Luc Bonnefoy | officer: President, Surgical | 103.8K | 0.03% | Aug 7, 2026 |
| Andrew J. Stewart | officer: President, GPIC | 103.2K | 0.03% | Aug 7, 2026 |
| Russel C. Robertson | director | 94.3K | 0.03% | May 28, 2026 |
| John Paulson | director | 89.8K | 0.03% | May 28, 2026 |
| Nathalie D. Bernier | director | 85.5K | 0.02% | May 28, 2026 |
| Thomas W. Sr. Ross | director | 85.2K | 0.02% | May 28, 2026 |
5 people have not refiled in the last 18 months (311.23M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 10, 2026 | Frederick Munschofficer: SVP, Controller and CAO | Sale | 52,900 | $16.78 | 45,831 |
| Aug 7, 2026 | Andrew C. von Eschenbachdirector | Sale | 6,059 | $16.58 | 63,733 |
| Aug 6, 2026 | Andrew C. von Eschenbachdirector | Sale | 12,500 | $16.50 | 69,792 |
| Mar 6, 2026 | Brent L. Saundersdirector, officer: CEO and Chairman of the Board | Purchase | 14,700 | $17.14 | 966,575 |
| Mar 6, 2026 | Sam Eldessoukyofficer: EVP and CFO | Purchase | 4,000 | $17.13 | 403,130 |
| Mar 6, 2026 | A. Robert D. Baileyofficer: EVP & Chief Legal Officer | Purchase | 14,600 | $17.15 | 231,890 |
| Mar 3, 2026 | Thomas W. Sr. Rossdirector | Purchase | 4,500 | $17.68 | 64,891 |
| Feb 27, 2026 | Andrew C. von Eschenbachdirector | Purchase | 4,364 | $18.31 | 66,450 |
| Mar 2, 2026 | Eduardo Alfonsodirector | Purchase | 4,300 | $17.90 | 9,555 |
| Feb 20, 2026 | Russel C. Robertsondirector | Purchase | 4,400 | $17.90 | 72,407 |
CongressHouse and Senate disclosures
Not reported.